-

Acadia Healthcare to Present at the 40th Annual J.P. Morgan Healthcare Conference

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference, which takes place January 10 – January 13, 2022. There will be a webcast of the Company’s presentation available on the Company’s website starting at 4:30 p.m. Eastern Time/3:30 p.m. Central Time on Wednesday, January 12, 2022.

The live webcast of the presentation will be available on the Company’s website, www.acadiahealthcare.com, by clicking on the “Investors” link. A replay of the presentation will also be available on the Company’s website for thirty days.

About Acadia Healthcare Company, Inc.

Acadia is a leading provider of behavioral healthcare services across the United States. As of September 30, 2021, Acadia operated a network of 230 behavioral healthcare facilities with approximately 10,200 beds in 40 states and Puerto Rico. With more than 20,000 employees serving approximately 70,000 patients daily, Acadia is the largest stand-alone behavioral health company in the U.S. Acadia provides behavioral healthcare services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Contacts

Gretchen Hommrich
Vice President, Investor Relations
(615) 861-6000

Industry:

Acadia Healthcare Company, Inc.

NASDAQ:ACHC
Release Versions
English
$Cashtags
$ACHC

Contacts

Gretchen Hommrich
Vice President, Investor Relations
(615) 861-6000

Social Media Profiles
AcadiaHealthcare/Facebook
AcadiaHealthcare/LinkedIn
More News From Acadia Healthcare Company, Inc.

Acadia Healthcare Updates PLGL Reserves Following Annual Actuarial Review, Lowers 2025 Guidance

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced an update to its professional and general liability (“PLGL”) reserves, following its annual, third-party actuarial review of anticipated PLGL costs. This update reflects higher expected expenses associated primarily with patient-related litigation. As a result, the Company now expects full-year 2025 Adjusted EBITDA in the range of $601 million to $611 million, compared to...

Acadia Healthcare to Participate in UBS 2025 Global Healthcare Conference

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in a fireside chat at the UBS Global Healthcare Conference, November 9 - 12, 2025, in Palm Beach Gardens, Florida. In connection with the conference, there will be an online webcast of the Company’s presentation available on the Company’s website starting at 1:45 p.m. Central Time / 2:45 p.m. Eastern Time on Tuesday, November 11, 2025. The live webcast of the presen...

Acadia Healthcare Reports Third Quarter 2025 Results

FRANKLIN, Tenn.--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Results Revenue totaled $851.6 million, an increase of 4.4% over the third quarter of 2024 Same facility revenue increased 3.7% compared with the third quarter of 2024, including an increase in revenue per patient day of 2.3% and an increase in patient days of 1.3% Same facility admission...
Back to Newsroom